The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
5/2/2012

California, Indiana, Missouri, North Carolina, Ohio, Virginia, Washington. clinicaltrials.gov

Related Summaries